International Conference on Pharmacy, Categories of Drugs and Drug Action - (ICPCDDA-27)


2nd - 3rd February, 2027 | Kyrenia, Cyprus

Multi-format (In-person/Virtual)

Registration Options

Explore conference registration categories designed for every mode of participation.

Important Dates

Pre-registration Deadline

3rd January, 2027

Paper Submission Deadline

8th January, 2027

Last Date Of Registration

18th January, 2027

Date Of Conference

2nd - 3rd February, 2027

Downloads

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3 SDG 3 — Good Health and Well-being
SDG 4 SDG 4 — Quality Education
SDG 9 SDG 9 — Industry, Innovation and Infrastructure
SDG 15 SDG 15 — Life on Land
SDG 16 SDG 16 — Peace, Justice and Strong Institutions
SDG 17 SDG 17 — Partnerships for the Goals
Explore

All Session Tracks

Track 01
Advancements in Pharmacology and Drug Action

This track focuses on the latest research in pharmacology, emphasizing the mechanisms of drug action and their therapeutic implications. Participants will explore novel pharmacological agents and their potential applications in clinical settings.

Track 02
Innovations in Pharmaceutical Chemistry

This session will delve into the synthesis, design, and characterization of pharmaceutical compounds. Discussions will highlight the role of chemical structures in determining drug efficacy and safety.

Track 03
Clinical Pharmacology and Patient Care

This track addresses the integration of clinical pharmacology into direct patient care practices. It aims to enhance understanding of personalized medicine and the optimization of therapeutic regimens.

Track 04
Neuropharmacology: Mechanisms and Applications

Focusing on the pharmacological effects on the nervous system, this session will cover the latest findings in neuropharmacology. Topics will include the role of neurotransmitters and the development of neuroactive drugs.

Track 05
Pharmacodynamics and Pharmacokinetics

This track will explore the principles of pharmacodynamics and pharmacokinetics in drug development and clinical application. Participants will discuss how these concepts influence drug efficacy and safety profiles.

Track 06
Toxicology and Drug Safety

This session will focus on the assessment of drug toxicity and its implications for patient safety. Discussions will include the evaluation of adverse drug reactions and the role of toxicology in drug development.

Track 07
Laboratory Medicine and Diagnostics

This track will highlight the importance of laboratory medicine in diagnosing and monitoring drug therapy. Participants will explore advancements in molecular diagnostics and their impact on patient outcomes.

Track 08
Medicinal Properties of Natural Products

This session will examine the therapeutic potential of natural products and their bioactive compounds. Discussions will focus on the mechanisms of action and the role of these substances in modern medicine.

Track 09
Chemical Biology in Drug Discovery

This track will explore the intersection of chemical biology and pharmacology in the discovery of new therapeutic agents. Participants will discuss innovative approaches to drug design and development.

Track 10
Pharmacy Practice and Healthcare Integration

This session will focus on the evolving role of pharmacy practice within the healthcare system. Discussions will include strategies for enhancing collaboration among healthcare professionals to improve patient care.

Track 11
Emerging Trends in Psychopharmacology

This track will address the latest developments in psychopharmacology, focusing on the treatment of mental health disorders. Participants will explore the efficacy and safety of new psychotropic medications and their mechanisms of action.